GS Investments Inc. Trims Stake in UnitedHealth Group Incorporated (NYSE:UNH)

GS Investments Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,443 shares of the healthcare conglomerate’s stock after selling 601 shares during the period. UnitedHealth Group makes up approximately 2.4% of GS Investments Inc.’s investment portfolio, making the stock its 13th biggest holding. GS Investments Inc.’s holdings in UnitedHealth Group were worth $5,283,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. Howard Capital Management Group LLC purchased a new position in UnitedHealth Group in the 3rd quarter worth about $341,000. Principal Financial Group Inc. raised its stake in shares of UnitedHealth Group by 11.3% during the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. BIP Wealth LLC grew its stake in UnitedHealth Group by 51.0% in the third quarter. BIP Wealth LLC now owns 610 shares of the healthcare conglomerate’s stock worth $357,000 after purchasing an additional 206 shares in the last quarter. Segall Bryant & Hamill LLC raised its position in UnitedHealth Group by 53.3% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 87,219 shares of the healthcare conglomerate’s stock valued at $50,995,000 after purchasing an additional 30,340 shares in the last quarter. Finally, Strategy Asset Managers LLC increased its stake in shares of UnitedHealth Group by 269.2% during the third quarter. Strategy Asset Managers LLC now owns 9,755 shares of the healthcare conglomerate’s stock valued at $5,703,000 after buying an additional 7,113 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

NYSE UNH opened at $503.05 on Thursday. The company has a fifty day moving average of $510.48 and a 200 day moving average of $548.22. The company has a market capitalization of $460.14 billion, a PE ratio of 32.45, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the business earned $5.83 earnings per share. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have commented on UNH. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Deutsche Bank Aktiengesellschaft lifted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a research report on Friday, January 10th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.